News and Updates

The QAIAx clinical trial explores how AGI can support veteran mental health through alternative sentencing and VR-based pro-social dating programs.

New trial data shows the Leqembi subcutaneous autoinjector offers similar efficacy to IV infusions, promising a more accessible future for Alzheimer’s care.

Despite recent clinical setbacks for Wainua, analysts weigh in on BridgeBio Pharma’s potential. Is the biotech stock undervalued? Read the latest analysis.

A groundbreaking clinical trial has begun in the DRC to test advanced Ebola treatments. Discover how this study aims to lower mortality rates worldwide.

New trial data shows denecimig offers consistent safety and efficacy for hemophilia A patients across all age groups. Learn the latest clinical findings.

The Maharashtra FDA has ordered a recall of Cadila Pharma’s Aciloc worth Rs 2.45 crore due to deceptive branding. Learn the details behind the major move.

Marksans Pharma to acquire German-based ABCnow GmbH, aiming to expand its EU market presence and streamline drug distribution and regulatory operations.

A new class of GLP-3 drugs is showing significant promise in Phase 3 trials for weight loss and diabetes. Learn how this breakthrough may reshape metabolic care.

A new miniature GLP-1 implant aims to simplify weight loss maintenance, offering a consistent alternative to injections. Discover the future of obesity care.

AstraZeneca’s latest clinical trial failure triggers industry-wide concerns about pipeline valuation and the stability of its high-stakes drug portfolio.